Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pan Pantziarka

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Ecancermedicalscience|December 20, 2014
Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agentPan Pantziarka, Gauthier Bouche, Lydie Meheus, et al.
Ecancermedicalscience|January 30, 2016
Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agentPan Pantziarka, Vidula Sukhatme, Gauthier Bouche, et al.
Ecancermedicalscience|July 31, 2014
Repurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agentPan Pantziarka, Gauthier Bouche, Lydie Meheus, et al.
Nature Reviews. Drug Discovery|June 8, 2026
Reply to 'Stimulating medicines repurposing in the EU: a pilot project'Pan Pantziarka, Patricia Vandamme, Alicia Soler, et al.
Frontiers in Pharmacology|March 29, 2021
An Open Access Database of Licensed Cancer DrugsPan Pantziarka, Rica Capistrano I, Arno De Potter, et al.
Ecancermedicalscience|December 1, 2016
Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agentPan Pantziarka, Gauthier Bouche, Vidula Sukhatme, et al.
Ecancermedicalscience|July 31, 2014
The Repurposing Drugs in Oncology (ReDO) ProjectPan Pantziarka, Gauthier Bouche, Lydie Meheus, et al.
Ecancermedicalscience|May 11, 2018
Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agentsPan Pantziarka, Vidula Sukhatme, Sergio Crispino, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 21, 2017
Perioperative therapies - Enhancing the impact of cancer surgery with repurposed drugsPan Pantziarka, Gauthier Bouche, Richard Sullivan, et al.
Ecancermedicalscience|March 3, 2015
Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agentAn Mt Van Nuffel, Vidula Sukhatme, Pan Pantziarka, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Ecancermedicalscience|December 20, 2014
Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agentPan Pantziarka, Gauthier Bouche, Lydie Meheus, et al.
Ecancermedicalscience|January 30, 2016
Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agentPan Pantziarka, Vidula Sukhatme, Gauthier Bouche, et al.
Ecancermedicalscience|July 31, 2014
Repurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agentPan Pantziarka, Gauthier Bouche, Lydie Meheus, et al.
Nature Reviews. Drug Discovery|June 8, 2026
Reply to 'Stimulating medicines repurposing in the EU: a pilot project'Pan Pantziarka, Patricia Vandamme, Alicia Soler, et al.
Frontiers in Pharmacology|March 29, 2021
An Open Access Database of Licensed Cancer DrugsPan Pantziarka, Rica Capistrano I, Arno De Potter, et al.
Ecancermedicalscience|December 1, 2016
Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agentPan Pantziarka, Gauthier Bouche, Vidula Sukhatme, et al.
Ecancermedicalscience|July 31, 2014
The Repurposing Drugs in Oncology (ReDO) ProjectPan Pantziarka, Gauthier Bouche, Lydie Meheus, et al.
Ecancermedicalscience|May 11, 2018
Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agentsPan Pantziarka, Vidula Sukhatme, Sergio Crispino, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 21, 2017
Perioperative therapies - Enhancing the impact of cancer surgery with repurposed drugsPan Pantziarka, Gauthier Bouche, Richard Sullivan, et al.
Ecancermedicalscience|March 3, 2015
Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agentAn Mt Van Nuffel, Vidula Sukhatme, Pan Pantziarka, et al.
Pageof 6